Gene · 248
Papers2,303
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
281 to 300 of 2,303
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insights into the Mechanism of CRISPR/Cas9-Based Genome Editing from Molecular Dynamics Simulations. | ACS Omega | 2023 | 36687047 | PubTator, text mining | PubMed |
| Anti-Inflammatory Effects of the 35kDa Hyaluronic Acid Fragment (B-HA/HA35). | J Inflamm Res | 2023 | 36686276 | PubTator, text mining | PubMed |
| Electrochemical (Bio)Sensing Devices for Human-Microbiome-Related Biomarkers. | Sensors (Basel) | 2023 | 36679633 | PubTator, text mining | PubMed |
| Metabolic Role of Autophagy in the Pathogenesis and Development of NAFLD. | Metabolites | 2023 | 36677026 | PubTator, text mining | PubMed |
| O-Glycomic and Proteomic Signatures of Spontaneous and Butyrate-Stimulated Colorectal Cancer Cell Line Differentiation. | Mol Cell Proteomics | 2023 | 36669592 | PubTator, text mining | PubMed |
| A phenotypic screen of Marfan syndrome iPSC-derived vascular smooth muscle cells uncovers GSK3β as a new target. | Stem Cell Reports | 2023 | 36669494 | PubTator, text mining | PubMed |
| Inhibiting the inhibitors: Development of the IAP inhibitor xevinapant for the treatment of locally advanced squamous cell carcinoma of the head and neck. | Cancer Treat Rev | 2023 | 36640618 | PubTator, text mining | PubMed |
| Synthesis, kinetic studies and in-silico investigations of novel quinolinyl-iminothiazolines as alkaline phosphatase inhibitors. | J Enzyme Inhib Med Chem | 2023 | 36629454 | PubTator, text mining | PubMed |
| Evaluation of the Anticancer and Probiotic Potential of Autochthonous (Wild) Lacticaseibacillus paracasei Strains from New Ecological Niches as a Possible Additive for Functional Dairy Foods. | Foods | 2023 | 36613399 | PubTator, text mining | PubMed |
| Prioritization of non-coding elements involved in non-syndromic cleft lip with/without cleft palate through genome-wide analysis of de novo mutations. | HGG Adv | 2023 | 36589413 | PubTator, text mining | PubMed |
| Modulation of RNA splicing enhances response to BCL2 inhibition in leukemia. | Cancer Cell | 2023 | 36563682 | PubTator, text mining | PubMed |
| Gut adaptation after gastric bypass in humans reveals metabolically significant shift in fuel metabolism. | Obesity (Silver Spring) | 2023 | 36541157 | PubTator, text mining | PubMed |
| Discovery of pan-IAP degraders via a CRBN recruiting mechanism. | Eur J Med Chem | 2023 | 36410083 | PubTator, text mining | PubMed |
| Design, synthesis and biological evaluation of 4-aminoquinoline derivatives as receptor-interacting protein kinase 2 (RIPK2) inhibitors. | J Enzyme Inhib Med Chem | 2023 | 36408835 | PubTator, text mining | PubMed |
| Molecular and Functional Characterization of Human Intestinal Organoids and Monolayers for Modeling Epithelial Barrier. | Inflamm Bowel Dis | 2023 | 36356046 | PubTator, text mining | PubMed |
| Applying CRISPR-Cas9 screens to dissect hematological malignancies. | Blood Adv | 2023 | 36355853 | PubTator, text mining | PubMed |
| Imidazole-amino acids. Conformational switch under tautomer and pH change. | Amino Acids | 2023 | 36319875 | PubTator, text mining | PubMed |
| A Review on the Mechanism and Applications of CRISPR/Cas9/Cas12/Cas13/Cas14 Proteins Utilized for Genome Engineering. | Mol Biotechnol | 2023 | 36163606 | PubTator, text mining | PubMed |
| Molecular Glues: The Adhesive Connecting Targeted Protein Degradation to the Clinic. | Biochemistry | 2023 | 35856839 | PubTator, text mining | PubMed |
| Gut-derived low-grade endotoxaemia, atherothrombosis and cardiovascular disease. | Nat Rev Cardiol | 2023 | 35840742 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/248/papers?page=15